Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesThe combination of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in the treatment of T4 stage gastric cancer
Surgical Oncology, 07/02/09
Guo MG et al. - In a review of the use of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in treatment of T4 stage gastric cancer, it was concluded that those who responded to docetaxel–cisplatin–fluorouracil, exhibited T downstaging, and subsequently received an R0 resection had a better chance of a cure vs surgery alone, according to a complete 3-yr follow-up.
Methods- Prognosis of local advanced gastric carcinoma is very poor.
- Impact on survival and the effects induced by the triple combination docetaxel–cisplatin–fluorouracil (DCF) as neoadjuvant chemotherapy was evaluated in 24 T4 stage gastric tumor pts.
- They received 2–3 cycles DCF chemotherapy, followed by radical gastric resection.
- Tumor downstaging detected by CT was obtained in 17 of 24 pts.
- Overall 3-yr survival rate was 68.2%.
- Pts who received R0 resection (19/22) showed a 3-yr survival rate of 78.9%.
- T downstaged pts (17/22) showed a higher 3-yr survival rate of 82.4%.
Related Articles
Nodal staging score: A tool to assess adequate staging of node-negative colon cancer
Journal of Clinical Oncology, 11/16/09
Relevance Score: 81%
Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer
Medical Oncology, 11/10/09
Relevance Score: 81%
Expression of L1 Cell Adhesion Molecule Is a Significant Prognostic Factor in pT3-stage Gastric Cancer
Anticancer Research, 11/10/09
Relevance Score: 81%
An evidence-based consensus statement on the role and application of endosonography in clinical practice
Endoscopy, 10/30/09
Relevance Score: 81%
The prognostic significance of bladder neck invasion in prostate cancer: is microscopic involvement truly a T4 disease
BJU International, 11/06/09
Relevance Score: 80%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery
Cancer Chemotherapy and Pharmacology, 12/17/09
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/17/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: A phase II study
International Journal of Cancer, 12/18/09
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study
Palliative Medicine, 12/18/09
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: An Eastern Cooperative Oncology Group Trial
Breast Cancer Research and Treatment, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor